Mohamed M. NasrAllah

Mohamed M. NasrAllah

Auto-generated profile, based on publicly available information

Mohamed M. NasrAllah

Department of Nephrology Kasr Al Ainy School of Medicine, Cairo University Cairo Egypt

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 February 2010 in Nephrology Dialysis Transplantation
Verified
Journal Article
Closed access
MNM. M. Nasrallah
M. M. Nasrallah
AEA. R. El-Shehaby
A. R. El-Shehaby
MSM. M. Salem
M. M. Salem
NON. A. Osman
N. A. Osman
ESE. El Sheikh
E. El Sheikh
UDU. A. Sharaf El Din
U. A. Sharaf El Din
Vascular calcification has detrimental consequences on chronic kidney disease (CKD) patients, yet its pathogenesis is not fully understood. Fibroblast growth factor-23 (FGF-23) is involved in the regulation of mineral metabolism which may in turn affect vascular calcification. Data on the relationship between FGF-23 and peripheral vascular calcification, using conventional radiographs, are conflicting, and less is known about its relation to aortic calcification. We conducted this study to investigate the relationship between FGF-23 and aortic calcification in a standard haemodialysis setting. The study included 65 haemodialysis patients (46 prevalent and 19 incident) on a three times 4-h dialysis schedule as well as 15 controls. Those with diabetes, oral anticoagulation or parathyroidectomy were excluded. Intact FGF-23, parathormone, lipids, calcium and phosphorus were measured. Aortic calcification index (ACI) was assessed by a non-contrast computerized tomography (CT) of the abdominal aorta. FGF-23 levels were higher among haemodialysis patients (4681.3 +/- 3906.1 pg/mL) compared to controls (98.2 +/- 51.9 pg/mL), P = 0.005. ACI was higher in haemodialysis patients (14.1 +/- 12) than controls (3.2 +/- 3.6), P = 0.009. FGF-23 (P < 0.0001) and systolic blood pressure (BP) (P < 0.0001) were independently related to ACI in stepwise multiple regression analysis of pooled analysis of haemodialysis patients, R(2) = 0.476; in subgroup analysis, the independent factors relating to ACI among prevalent dialysis patients were systolic BP (P < 0.0001), FGF-23 (P = 0.002) and age (P = 0.012), R(2)=0.48; whereas in incident patients, only FGF-23 was associated with ACI (P = 0.007), R(2) = 0.37. In haemodialysis patients, FGF-23 and ACI were significantly increased, and FGF-23 was independently associated with aortic calcification.

20 September 2012 in Zeitschrift für Rheumatologie
Verified
Journal Article
Closed access
PDF file
TGTamer A Gheita
Tamer A Gheita
HRH.A. Raafat
H.A. Raafat
SSS. Sayed
S. Sayed
HEH. El-Fishawy
H. El-Fishawy
MNM.M. Nasrallah
M.M. Nasrallah
EAE. Abdel-Rasheed
E. Abdel-Rasheed

31 May 2014 in Clinical Kidney Journal
Verified
Journal Article
Open access
MNM. M. NasrAllah
M. M. NasrAllah
NON. A. Osman
N. A. Osman
Fasting during the month of Ramadan is a religious obligation for Muslims who represent 20% of the world population. This study explores the safety of fasting for a whole month among patients with chronic kidney disease (CKD) with the possible risk of dehydration and hyperviscosity leading to deterioration of kidney functions and vascular thrombosis. We followed CKD patients with stable kidney function who chose to fast during the month of Ramadan. A group of nonfasting CKD patients served as controls. Serum creatinine was recorded at the beginning of the month, after 1 week of fasting, at the end of the month and 3 months later. Patients were followed for major adverse cardiovascular events (MACE). A total of 131 CKD patients were recruited and included in two groups: fasting and nonfasting (mean baseline estimated glomerular filtration rate 27.7, SD 13 and 21.5, SD 11.8 mL/min/1.73 m2, respectively). A rise of serum creatinine was noted during fasting in 60.4% of patients by Day 7 and was associated with intake of renin angiotensin aldosterone system antagonists [relative risk (RR) 2, P = 0.002]. Adverse cardiovascular events were observed in six patients in the fasting cohort and were associated with a rise of serum creatinine after 1 week of fasting (P = 0.009) and the presence of pre-existing cardiovascular disease (RR 15, P = 0.001); the latter association was confirmed by logistic regression analysis. Only one event was recorded in the nonfasting group, P = 0.036. MACE occurred more frequently among fasting CKD patients with pre-existing cardiovascular disease and were predicted by an early rise of serum creatinine.

1 November 2015 in Journal of Renal Nutrition
Verified
Journal Article
Closed access
NONoha A. Osman
Noha A. Osman
SHSafaa M. Hassanein
Safaa M. Hassanein
MLMarwa M. Leil
Marwa M. Leil
MNMohamed M. NasrAllah
Mohamed M. NasrAllah

6 November 2013 in Nephron Extra
Verified
Journal Article
Open access
PDF file
MNMohamed M. NasrAllah
Mohamed M. NasrAllah
AEAmal R. El-Shehaby
Amal R. El-Shehaby
NONoha A. Osman
Noha A. Osman
TFTarek Fayad
Tarek Fayad
ANAmr Nassef
Amr Nassef
UDUsama A.A. Sharaf El Din
Usama A.A. Sharaf El Din
Background: Fibroblast growth factor-23 (FGF-23) has been linked to vascular calcification, ventricular hypertrophy and mortality in chronic kidney disease (CKD), although these links may not be direct and independent. Similar grave outcomes are associated with inflammation and oxidative stress in CKD. Recently, accumulating evidence has linked components of phosphate homeostasis to inflammation and oxidative stress. The interaction between the triad of inflammation, FGF-23 and cardiovascular outcomes is underinvestigated. Methods: We studied 65 patients with stage 5 CKD on hemodialysis. Serum levels of FGF-23, high-sensitivity C-reactive protein (hsCRP), endogenous soluble receptor of advanced glycation end products (esRAGE), advanced oxidation protein products (AOPP), parathormone, lipids, calcium and phosphorous were measured. The aortic calcification index (ACI) was determined using non-contrast CT scans of the abdominal aorta. Results: FGF-23 was elevated (mean: 4,681 pg/ml, SD: 3,906) and correlated with hsCRP, esRAGE, AOPP, dialysis vintage and phosphorus in univariate analysis. In multiple regression analysis, hsCRP, AOPP and phosphorus but not esRAGE were all significantly correlated to FGF-23 (R2 = 0.7, p < 0.001). In univariate analysis, ACI correlated with hsCRP, esRAGE, FGF-23, dialysis vintage, systolic blood pressure (BP) and serum cholesterol. In multiple regression analysis not including inflammation markers, ACI was associated with FGF-23. However, inclusion of inflammation markers in another multiple regression analyses showed that ACI correlated with hsCRP, BP, dialysis vintage and esRAGE but not with FGF-23 (R2 = 0.65, p < 0.001). Conclusion: FGF-23 is strongly correlated to various markers of inflammation and oxidative stress in hemodialysis patients. The association between FGF-23 and vascular calcification was mitigated when corrected for inflammation markers.

1 October 2016 in International Journal of Cardiology
Verified
Journal Article
Closed access
MNMohamed M. NasrAllah
Mohamed M. NasrAllah
ANAmr Nassef
Amr Nassef
TETarik H. Elshaboni
Tarik H. Elshaboni
FMFadia Morise
Fadia Morise
NONoha A. Osman
Noha A. Osman
UDUsama A. Sharaf El Din
Usama A. Sharaf El Din